Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
A quick update on the bivalent boosters - by Eric Topol
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Bivalent mRNA booster effective, 'essential' for older adults
Study asks why uptake of bivalent COVID boosters low
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
A quick update on the bivalent boosters - by Eric Topol
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada | medRxiv
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
Why payers should be preparing now for new COVID-19 boosters
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
Real-world data show new Covid boosters increase protection
Eric Topol on X: "The BA.5 bivalent booster's effectiveness: by April 2023, "individuals previously vaccinated only with wild-type vaccines had little protection against Covid-19 hospital admission" restored by the booster (24K cases,
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
New Omicron-specific vaccines offer similar protection to existing boosters
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
